ROIV
Price
$10.94
Change
+$0.20 (+1.86%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
7.96B
34 days until earnings call
SLNO
Price
$42.51
Change
-$0.55 (-1.28%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.83B
70 days until earnings call
Ad is loading...

ROIV vs SLNO

Header iconROIV vs SLNO Comparison
Open Charts ROIV vs SLNOBanner chart's image
Roivant Sciences
Price$10.94
Change+$0.20 (+1.86%)
Volume$94.2K
Capitalization7.96B
Soleno Therapeutics
Price$42.51
Change-$0.55 (-1.28%)
Volume$6.49K
Capitalization1.83B
ROIV vs SLNO Comparison Chart
Loading...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ROIV vs. SLNO commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROIV is a Hold and SLNO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (ROIV: $10.74 vs. SLNO: $43.06)
Brand notoriety: ROIV and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROIV: 118% vs. SLNO: 58%
Market capitalization -- ROIV: $7.82B vs. SLNO: $1.86B
ROIV [@Biotechnology] is valued at $7.82B. SLNO’s [@Biotechnology] market capitalization is $1.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $385.53B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROIV’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • ROIV’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROIV’s TA Score shows that 3 TA indicator(s) are bullish while SLNO’s TA Score has 3 bullish TA indicator(s).

  • ROIV’s TA Score: 3 bullish, 5 bearish.
  • SLNO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SLNO is a better buy in the short-term than ROIV.

Price Growth

ROIV (@Biotechnology) experienced а -6.69% price change this week, while SLNO (@Biotechnology) price change was -6.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.05%. For the same industry, the average monthly price growth was -1.49%, and the average quarterly price growth was -2.91%.

Reported Earning Dates

ROIV is expected to report earnings on Jun 25, 2025.

SLNO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-7.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.96B) has a higher market cap than SLNO($1.83B). SLNO YTD gains are higher at: -4.205 vs. ROIV (-9.214). ROIV has higher annual earnings (EBITDA): 4.15B vs. SLNO (-136.5M). ROIV has more cash in the bank: 5.39B vs. SLNO (257M). SLNO has less debt than ROIV: SLNO (3.03M) vs ROIV (52.7M). ROIV has higher revenues than SLNO: ROIV (129M) vs SLNO (0).
ROIVSLNOROIV / SLNO
Capitalization7.96B1.83B434%
EBITDA4.15B-136.5M-3,041%
Gain YTD-9.214-4.205219%
P/E Ratio1.97N/A-
Revenue129M0-
Total Cash5.39B257M2,096%
Total Debt52.7M3.03M1,740%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ROIVSLNO
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
70%
Bearish Trend 7 days ago
79%
Momentum
ODDS (%)
Bearish Trend 7 days ago
69%
Bearish Trend 7 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 7 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
70%
Bearish Trend 7 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
68%
Bearish Trend 7 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
72%
Bullish Trend 12 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
72%
Bearish Trend 22 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
70%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
71%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PAMC46.720.13
+0.28%
Pacer Lunt MidCap Multi-Factor Alt ETF
XTEN44.03-0.07
-0.16%
BondBloxx Bloomberg Ten YrTrgDurUSTrsETF
SCHE25.81-0.14
-0.54%
Schwab Emerging Markets Equity ETF™
GEM31.09-0.23
-0.73%
Goldman Sachs ActiveBeta® EMkts Eq ETF
DEFI105.74-3.09
-2.83%
Hashdex Bitcoin ETF

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.03%
IMVT - ROIV
50%
Loosely correlated
-3.11%
AXON - ROIV
43%
Loosely correlated
-0.23%
ALDX - ROIV
41%
Loosely correlated
-3.44%
DYN - ROIV
40%
Loosely correlated
-3.65%
STOK - ROIV
40%
Loosely correlated
-0.89%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-0.12%
BRNS - SLNO
56%
Loosely correlated
-8.74%
KANT - SLNO
45%
Loosely correlated
+2.38%
XENE - SLNO
42%
Loosely correlated
-0.42%
KYMR - SLNO
40%
Loosely correlated
-2.49%
ACLX - SLNO
40%
Loosely correlated
-2.49%
More